Eisai
4523.T
#1820
Rank
โ‚ฌ8.50 B
Marketcap
30,14ย โ‚ฌ
Share price
-2.00%
Change (1 day)
-38.35%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): โ‚ฌ0.40 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚ฌ5.06 Billion. In 2023 the company made an earning of โ‚ฌ0.49 Billion, an increase over its 2022 earnings that were of -โ‚ฌ21.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ0.40 B-18.71%
2023 โ‚ฌ0.49 B-2392.87%
2022 -โ‚ฌ21.67 Million-103.6%
2021 โ‚ฌ0.60 B-39.52%
2020 โ‚ฌ0.99 B7.3%
2019 โ‚ฌ0.92 B17.23%
2018 โ‚ฌ0.79 B86.06%
2017 โ‚ฌ0.42 B-23.64%
2016 โ‚ฌ0.55 B27.28%
2015 โ‚ฌ0.43 B22.08%
2014 โ‚ฌ0.35 B-46.11%
2013 โ‚ฌ0.66 B-21.67%
2012 โ‚ฌ0.84 B-20.72%
2011 โ‚ฌ1.07 B-8.44%
2010 โ‚ฌ1.16 B18.85%
2009 โ‚ฌ0.98 B